Literature DB >> 1411284

Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change.

A P Jenkins1, W S Nukajam, I S Menzies, B Creamer.   

Abstract

In normal adults intestinal permeation of ingested 51Cr-ethylenediaminetetraacetic acid (EDTA) is greater than that of lactulose. This difference is abolished in patients with ileostomies, suggesting that it results from colonic permeation of 51Cr-EDTA, which, unlike lactulose, resists bacterial degradation. To investigate the effect of an increase in colonic permeability on absorption of the two molecules, lactulose (5 g) and 51Cr-EDTA (50 microCi) were given orally in isosmolar solution to 11 patients with colitis, and their 24-h urinary excretion measured. By comparison the effect of an increase in small-intestinal permeability induced by ingestion of a hyperosmolar solution (4240 mosm/l) was measured in 10 healthy adults. Hyperosmolar stress increased the 24-h urinary excretion of 51Cr-EDTA above the normal mean + 2 standard deviations (3.31%) in all 10 healthy subjects, and in all of these excretion of lactulose was also increased (greater than 1.06%). In contrast, although seven colitics had a urinary excretion of 51Cr-EDTA above the normal mean + 2 SD, in only two of these patients was recovery of lactulose increased. This suggests that simultaneous administration of lactulose and 51Cr-EDTA may enable permeability changes affecting the colon alone to be distinguished from those involving the small intestine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1411284     DOI: 10.3109/00365529209011181

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  Intestinal permeability, leaky gut, and intestinal disorders.

Authors:  D Hollander
Journal:  Curr Gastroenterol Rep       Date:  1999-10

2.  Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease.

Authors:  K Teahon; S Somasundaram; T Smith; I Menzies; I Bjarnason
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

3.  Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion.

Authors:  M Camilleri; A Nadeau; J Lamsam; S Linker Nord; M Ryks; D Burton; S Sweetser; A R Zinsmeister; R Singh
Journal:  Neurogastroenterol Motil       Date:  2009-07-13       Impact factor: 3.598

4.  Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease.

Authors:  Jaya Benjamin; Govind K Makharia; Vineet Ahuja; Mani Kalaivani; Yogendra K Joshi
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

5.  Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA.

Authors:  Julius Z H von Martels; Arno R Bourgonje; Hermie J M Harmsen; Klaas Nico Faber; Gerard Dijkstra
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

6.  The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.

Authors:  Sven C D van IJzendoorn; Pascal Derkinderen
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.